Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Topical therapy is the mainstay of treatment for mild to moderate psoriasis and serves as a useful adjunct support to systemic therapy in severe disease. However, efficacy and compliance to topical therapy in psoriasis have been a major concern. Solid lipid nanoparticles (SLN) are a new pharmaceutical delivery system or pharmaceutical formulation. These are made of solid lipids which remain solid at room temperature. Dithranol used to treat skin diseases such as psoriasis, eczema and chronic dermatoses. It is a drug of keratolytic category. Solid lipid nanoparticles of dithranol will result in better delivery of drug to the site of action. Psoriasis treatment by dithranol loaded SLN is worthy of study.